Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 24, 2016
Why do young adults tan?
C L Thomas, P Fernandez Peñas
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 21, 2017
Experience of skin cancer and contact with health professionals is associated with increased skin cancer knowledge, but not sun safety knowledge or behaviour
C L Thomas, P Fernandez-Peñas
Actas Dermo-Sifiliograficas
|
December 6, 2025
A Systematic Review of Treatments for Cutaneous Chronic Graft-versus-Host Disease
M Zhou, M Mansilla-Polo, P Fernandez-Peñas
Clinical and Experimental Dermatology
|
January 9, 2019
Vitiligo-like depigmentation in oncology patients treated with immunotherapies for nonmelanoma metastatic cancers
R C Liu, G Consuegra, S Chou, et al.
Lupus
|
November 11, 2009
Squamous cell carcinoma arising in a recent plaque of discoid lupus erythematous, in a sun-protected area
N Parikh, J Choi, M Li, et al.
Actas Dermo-Sifiliograficas
|
September 20, 2016
Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management
S J E Hwang, R Anforth, G Carlos, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 18, 2021
Toxic epidermal necrolysis-like lupus erythematosus: a condition to exclude in all patients with possible Stevens-Johnson syndrome/toxic epidermal necrolysis
K Truong, S Goldinger, J Kim, et al.
The British Journal of Dermatology
|
January 11, 2012
Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis
P Fernandez-Peñas, M Jones-Caballero, O Espallardo, et al.
The British Journal of Dermatology
|
July 22, 2014
Cutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeks
R Anforth, G Carlos, A Clements, et al.
Clinical and Experimental Dermatology
|
November 22, 2020
Successful treatment of highly refractory necrobiotic xanthogranuloma with peginterferon alfa-2a
K Truong, V Venning, T Wain, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 24, 2016
Why do young adults tan?
C L Thomas, P Fernandez Peñas
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 21, 2017
Experience of skin cancer and contact with health professionals is associated with increased skin cancer knowledge, but not sun safety knowledge or behaviour
C L Thomas, P Fernandez-Peñas
Actas Dermo-Sifiliograficas
|
December 6, 2025
A Systematic Review of Treatments for Cutaneous Chronic Graft-versus-Host Disease
M Zhou, M Mansilla-Polo, P Fernandez-Peñas
Clinical and Experimental Dermatology
|
January 9, 2019
Vitiligo-like depigmentation in oncology patients treated with immunotherapies for nonmelanoma metastatic cancers
R C Liu, G Consuegra, S Chou, et al.
Lupus
|
November 11, 2009
Squamous cell carcinoma arising in a recent plaque of discoid lupus erythematous, in a sun-protected area
N Parikh, J Choi, M Li, et al.
Actas Dermo-Sifiliograficas
|
September 20, 2016
Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management
S J E Hwang, R Anforth, G Carlos, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 18, 2021
Toxic epidermal necrolysis-like lupus erythematosus: a condition to exclude in all patients with possible Stevens-Johnson syndrome/toxic epidermal necrolysis
K Truong, S Goldinger, J Kim, et al.
The British Journal of Dermatology
|
January 11, 2012
Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis
P Fernandez-Peñas, M Jones-Caballero, O Espallardo, et al.
The British Journal of Dermatology
|
July 22, 2014
Cutaneous adverse events in patients treated with BRAF inhibitor-based therapies for metastatic melanoma for longer than 52 weeks
R Anforth, G Carlos, A Clements, et al.
Clinical and Experimental Dermatology
|
November 22, 2020
Successful treatment of highly refractory necrobiotic xanthogranuloma with peginterferon alfa-2a
K Truong, V Venning, T Wain, et al.
Page
of 2